查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606662

DNA/基因晶片市場：按產品類型、陣列類型、應用和最終用戶 - 2025-2030 年全球預測

DNA & Gene Chip Market by Product (Consumables, Instruments), Array Type (cDNA-Based Microarray, Oligonucleotide-Based Microarray), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年DNA和基因晶片市值為87.7億美元，預計2024年將達到97.1億美元，複合年成長率為11.34%，預計到2030年將達到186.1億美元。

DNA 和基因晶片市場是生物技術和基因組學領域的一個專門領域，專注於促進基因表現和遺傳變異快速分析的技術。這些晶片也稱為微陣列，是推動個人化醫療、診斷和治療方法開發的重要工具。需要的是實現大規模基因組研究、加速藥物發現並提高對疾病的了解。應用涵蓋腫瘤學、藥物基因組學、遺傳分析和農業生物技術，為實驗室、醫院和生物製藥公司等廣泛的最終用戶提供服務。市場的主要驅動力是個人化醫療需求的不斷成長、技術進步帶來的成本效率和高通量性能以及生物技術行業的擴張。此外，越來越多的遺傳性疾病和癌症患者需要高效的診斷工具，這提供了潛在的成長機會。

主要市場統計
基準年[2023] 87.7億美元
預測年份 [2024] 97.1億美元
預測年份 [2030] 186.1億美元
複合年成長率（%） 11.34%

然而，成長也存在障礙，例如與技術相關的高成本以及由於產生大量資訊而導致的資料管理挑戰。智慧財產權問題也是一個障礙。開拓新興市場、增強資料分析技術和整合人工智慧等機會提供了強大的成長途徑。公司應專注於開發中小型企業負擔得起且易於使用的微陣列解決方案。此外，擴大農業應用，例如作物改良和動物遺傳學，可以開拓新的收益來源。

創新的關鍵是投資開發能夠簡化資料解釋並提高準確性的平台。此外，重點可能是將微陣列技術與 CRISPR 和次世代定序儀相結合，以改善診斷和治療策略。了解以快速技術變革和嚴格監管政策為特徵的競爭格局，有助於公司在市場中策略定位。 DNA和基因晶片市場潛力巨大，預計將穩定成長，但企業需要有效應對挑戰，利用技術進步來抓住新機會。

市場動態：快速發展的 DNA 和基因晶片市場的關鍵市場洞察

DNA/基因晶片市場正因供需的動態互動而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 用於遺傳分析和診斷的 DNA 和基因晶片的需求不斷成長
    • 個人化醫療在癌症治療中的快速採用
    • 對早期癌症檢測和癌症診斷的需求不斷增加
  • 市場限制因素
    • 缺乏技術精湛、經驗豐富的專業人員
  • 市場機會
    • DNA/基因晶片小型化研究進展
    • DNA 和基因晶片的政府策略資助和舉措
  • 市場挑戰
    • 對基因表現調控和替代技術可用性的擔憂

波特五力：駕馭 DNA 與基因晶片市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解DNA/基因晶片市場的外部影響

外部宏觀環境因素在塑造 DNA 和基因晶片市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解 DNA/基因晶片市場的競爭狀況

DNA 和基因晶片市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣DNA及基因晶片市場廠商績效評估

FPNV定位矩陣是評估DNA和基因晶片市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，描繪 DNA 和基因晶片市場的成功之路

DNA 和基因晶片市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告提供了涵蓋關鍵重點領域的市場全面分析：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 用於遺傳分析和診斷的 DNA/基因晶片的需求不斷增加
      • 個人化醫療在癌症治療中的快速引入
      • 對癌症早期檢測和診斷的需求不斷增加
    • 抑制因素
      • 缺乏技術精湛、經驗豐富的專業人員
    • 機會
      • DNA/基因晶片小型化的到來
      • 關於 DNA 和基因晶片的政府策略資助和舉措
    • 任務
      • 對基因表現控制和替代技術可用性的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 DNA/基因晶片市場：依產品

  • 消耗品
  • 裝置

第7章依序列類型分類的DNA/基因晶片市場

  • 基於 cDNA 的微陣列
  • 基於寡核苷酸的微陣列

第8章 DNA/基因晶片市場：依應用分類

  • 診斷
  • 藥物發現與開發
  • 基因組學
  • 個人化醫療

第 9 章 DNA/基因晶片市場：依最終用戶分類

  • 學術研究所
  • 醫院和臨床實驗室
  • 製藥和生物技術公司

第10章美洲DNA/基因晶片市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太DNA/基因晶片市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲的DNA和基因晶片市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 23andMe, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Biomerieux SA
  • Bioneer Corporation
  • CapitalBio Technology Co., Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Greiner Bio-One International GmbH
  • Illumina, Inc.
  • Integrated Dna Technologies
  • LifeGen Technologies, LLC
  • Macrogen Inc.
  • Merck KGaA
  • Microarrays Inc.
  • Ocimum Biosolutions Ltd.
  • Perkin Elmer, Inc.
  • Promega Corporation
  • Savyon Diagnostics
  • Scienion AG by a Bico Company
  • Shanghai Biochip Co Ltd.
  • Sophia Genetics SA
  • Surmodics Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Veritas Genetics, Inc.
Product Code: MRR-521BAA36EBAB

The DNA & Gene Chip Market was valued at USD 8.77 billion in 2023, expected to reach USD 9.71 billion in 2024, and is projected to grow at a CAGR of 11.34%, to USD 18.61 billion by 2030.

The DNA and Gene Chip market represents a specialized segment within the biotechnology and genomics field, focusing on technology facilitating the rapid analysis of gene expression and genetic variations. These chips, also called microarrays, are indispensable tools for advancing personalized medicine, diagnostics, and therapeutic development. Their necessity lies in enabling large-scale genomic research, accelerating drug discovery, and enhancing disease understanding. Applications span across oncology, pharmacogenomics, genetic analysis, and agricultural biotechnology, serving a wide range of end-users, including research labs, hospitals, and biopharmaceutical companies. The market is predominantly driven by the increasing demand for personalized medicine, technological advancements leading to cost-effective and high-throughput capabilities, and the expanding biotech industry. Furthermore, the rise in genetic disorders and cancer cases necessitates efficient diagnostic tools, providing potential growth opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 8.77 billion
Estimated Year [2024] USD 9.71 billion
Forecast Year [2030] USD 18.61 billion
CAGR (%) 11.34%

However, certain growth barriers include the high costs associated with technology and data management challenges due to the vast amount of information generated. Intellectual property issues also present obstacles. Opportunities for tapping into emerging markets, enhancing data analysis techniques, and integrating artificial intelligence present significant avenues for growth. Companies should focus on developing affordable and user-friendly microarray solutions to cater to small and medium-sized enterprises. Moreover, expanding applications in agriculture for crop improvement and animal genetics could open new revenue streams.

For innovation, investing in platform development that simplifies data interpretation and enhances accuracy will be key. Moreover, research could focus on combining microarray technology with CRISPR and next-generation sequencing for improved diagnostics and treatment strategies. Understanding the competitive landscape, marked by rapid technological shifts and stringent regulatory policies, can aid businesses in strategically positioning themselves in the market. With a robust growth outlook, the DNA and Gene Chip market holds substantial potential, but companies need to effectively address challenges and leverage technological advancements to capitalize on emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving DNA & Gene Chip Market

The DNA & Gene Chip Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing need of DNA & gene chip for genetic analysis and diagnostics
    • Surging adoption of personalized medicines for cancer treatments
    • Increase in the demand for early cancer detection and cancer diagnosis
  • Market Restraints
    • Lack of skilled and experienced subject experts
  • Market Opportunities
    • Emerging miniaturization of DNA & gene chip
    • Strategic government fundings and initiatives for DNA & gene chip
  • Market Challenges
    • Concern associated with gene expression regulation and availability of alternative technologies

Porter's Five Forces: A Strategic Tool for Navigating the DNA & Gene Chip Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the DNA & Gene Chip Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the DNA & Gene Chip Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the DNA & Gene Chip Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the DNA & Gene Chip Market

A detailed market share analysis in the DNA & Gene Chip Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the DNA & Gene Chip Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the DNA & Gene Chip Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the DNA & Gene Chip Market

A strategic analysis of the DNA & Gene Chip Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the DNA & Gene Chip Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Agilent Technologies, Inc., Arrayit Corporation, Biomerieux SA, Bioneer Corporation, CapitalBio Technology Co., Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Greiner Bio-One International GmbH, Illumina, Inc., Integrated Dna Technologies, LifeGen Technologies, LLC, Macrogen Inc., Merck KGaA, Microarrays Inc., Ocimum Biosolutions Ltd., Perkin Elmer, Inc., Promega Corporation, Savyon Diagnostics, Scienion AG by a Bico Company, Shanghai Biochip Co Ltd., Sophia Genetics SA, Surmodics Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Veritas Genetics, Inc..

Market Segmentation & Coverage

This research report categorizes the DNA & Gene Chip Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Instruments.
  • Based on Array Type, market is studied across cDNA-Based Microarray and Oligonucleotide-Based Microarray.
  • Based on Application, market is studied across Diagnostics, Drug Discovery & Development, Genomics, and Personalized Medicine.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospitals & Clinical Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need of DNA & gene chip for genetic analysis and diagnostics
      • 5.1.1.2. Surging adoption of personalized medicines for cancer treatments
      • 5.1.1.3. Increase in the demand for early cancer detection and cancer diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled and experienced subject experts
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging miniaturization of DNA & gene chip
      • 5.1.3.2. Strategic government fundings and initiatives for DNA & gene chip
    • 5.1.4. Challenges
      • 5.1.4.1. Concern associated with gene expression regulation and availability of alternative technologies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. DNA & Gene Chip Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments

7. DNA & Gene Chip Market, by Array Type

  • 7.1. Introduction
  • 7.2. cDNA-Based Microarray
  • 7.3. Oligonucleotide-Based Microarray

8. DNA & Gene Chip Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Drug Discovery & Development
  • 8.4. Genomics
  • 8.5. Personalized Medicine

9. DNA & Gene Chip Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Clinical Laboratories
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas DNA & Gene Chip Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific DNA & Gene Chip Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa DNA & Gene Chip Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 23andMe, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Arrayit Corporation
  • 4. Biomerieux SA
  • 5. Bioneer Corporation
  • 6. CapitalBio Technology Co., Ltd.
  • 7. Eurofins Scientific SE
  • 8. F. Hoffmann-La Roche AG
  • 9. Greiner Bio-One International GmbH
  • 10. Illumina, Inc.
  • 11. Integrated Dna Technologies
  • 12. LifeGen Technologies, LLC
  • 13. Macrogen Inc.
  • 14. Merck KGaA
  • 15. Microarrays Inc.
  • 16. Ocimum Biosolutions Ltd.
  • 17. Perkin Elmer, Inc.
  • 18. Promega Corporation
  • 19. Savyon Diagnostics
  • 20. Scienion AG by a Bico Company
  • 21. Shanghai Biochip Co Ltd.
  • 22. Sophia Genetics SA
  • 23. Surmodics Inc.
  • 24. Sysmex Corporation
  • 25. Thermo Fisher Scientific Inc.
  • 26. Twist Bioscience Corporation
  • 27. Veritas Genetics, Inc.

LIST OF FIGURES

  • FIGURE 1. DNA & GENE CHIP MARKET RESEARCH PROCESS
  • FIGURE 2. DNA & GENE CHIP MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DNA & GENE CHIP MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DNA & GENE CHIP MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DNA & GENE CHIP MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DNA & GENE CHIP MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DNA & GENE CHIP MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DNA & GENE CHIP MARKET DYNAMICS
  • TABLE 7. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DNA & GENE CHIP MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CDNA-BASED MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DNA & GENE CHIP MARKET SIZE, BY OLIGONUCLEOTIDE-BASED MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DNA & GENE CHIP MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. DNA & GENE CHIP MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. DNA & GENE CHIP MARKET, FPNV POSITIONING MATRIX, 2023